EU project to study cell and gene therapy in heart disease

Thursday 14 July 2011

The European Commission has awarded €5.3 million over four years to a consortium led by Ark Therapeutics Group Plc to investigate the possible use of gene and cell therapy, along with stents, in the treatment of coronary heart disease.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom